At the end of the last century, a far-sighted 'working party'held in Sydney, Australia
addressed the clinicopathological issues related to gastric inflammatory diseases. A few …

Abstract Purpose of Review CoronaVirus Disease of 2019 (COVID-19) has negatively
influenced the management of multiple conditions in regards to the gastroenterology patient …

The infection and chronic inflammatory response generated by Helicobacter pylori is a
global health concern. This pathogen is characterized as a major risk factor in the …

Introduction. Helicobacter pylori is the leading cause of peptic ulcers and gastric cancer. The
most common treatment regimens use combinations of two or three antibiotics and a proton …

For decades, antimicrobial therapy for Helicobacter pylori infection has been given
empirically, and the results of therapy (success or failure) have either not been confirmed or …

Available guidelines and meta-analyses do not yet address H. pylori as an infectious
disease. The diagnosis and management and treatment success of H. pylori infections trails …

Background There has been an increase in resistance to many of the antimicrobials used to
treat Helicobacter pylori (H. pylori) nationally and internationally. Primary clarithromycin …

Abstract Objectives The management of Helicobacter pylori in Vietnam is becoming
progressively more difficult due to increasing antibiotic resistance, particularly to …

Background With the increasing resistance to antimicrobial agents, susceptibility‐guided
tailored therapy has been emerging as an ideal strategy for Helicobacter pylori treatment …

Helicobacter pylori is a class I carcinogen that infects more than 100 million individuals in
the United States. Antimicrobial therapy for H. pylori has typically been prescribed …